Exercisers May Have Better Breast Cancer Survival

Publication
Article
OncologyONCOLOGY Vol 20 No 12
Volume 20
Issue 12

Women who reported the highest levels of physical activity in the year before they were diagnosed with breast cancer may have higher survival

Women who reported the highest levels of physical activity in the year before they were diagnosed with breast cancer may have higher survival, according to a new study. Published in the October 15, 2006, issue of CANCER, the study found that obese and overweight women who had higher levels of moderate or vigorous recreational physical activity within 1 year before diagnosis tended to have better 5-year survival patterns compared to other groups. Women of ideal body weight did not experience survival benefits from exercise; more remote histories of physical activity also had no impact on survival.

In breast cancer, clinical indicators, such as tumor size, regional lymph node involvement, and estrogen-receptor status, have been shown to influence outcome. Other lifestyle factors, such as weight, may also predict disease course. While these factors are statistically associated with outcome to some degree, they may not explain all the variation that has lead researchers to search for additional prognostic factors, such as physical activity.

Impact on Prognosis

While exercise has been shown to be a significant factor in preventing breast cancer, its role in prognosis after diagnosis remains unclear but has also been infrequently studied. Page E. Abrahamson, PHD, now at the Fred Hutchinson Cancer Research Center in Seattle, led researchers while at the University of North Carolina, Chapel Hill, to investigate the relationship between prediagnosis physical activity and survival in 1,264 women with breast cancer.

The authors report that prediagnosis exercise did improve disease outcome. Survival modestly increased among women with body mass index (BMI) greater than 25 who reported highest levels of physical activity within 1 year of diagnosis. There was no benefit for women with BMI less than 25. Also, physical activity in adolescence or early adulthood had no impact on survival.

"Given that obesity is relatively well established as a poor prognostic factor in breast cancer," conclude the authors, "it is hopeful that activity may provide an opportunity to improve survival in this subpopulation."

Recent Videos
Regardless of disease burden or disease progression speed on front-line therapy, trastuzumab deruxtecan appears effective in HER2-low breast cancer.
Performance status, age, and comorbidities may impact benefit seen with immunotherapy vs chemotherapy in patients with breast cancer.
Related Content